Patents Assigned to Aesgen, Inc.
  • Patent number: 7186517
    Abstract: The present invention provides compositions and a method for monitoring breast cancer treatment.
    Type: Grant
    Filed: July 30, 2004
    Date of Patent: March 6, 2007
    Assignee: Aesgen, Inc.
    Inventors: Larry J. Suva, V. Suzanne Klimberg
  • Patent number: 7041651
    Abstract: Provided is a composition and a method for increasing cellular uptake of bioactive agents, particularly those compounds termed “small molecules” into the cells of mammalian tissue, such as the epithelial cells of the mucosa.
    Type: Grant
    Filed: March 9, 2004
    Date of Patent: May 9, 2006
    Assignee: Aesgen, Inc.
    Inventors: Robert G. Petit, II, Edward C. Shinal
  • Publication number: 20040176319
    Abstract: Provided is a composition and a method for increasing cellular uptake of bioactive agents, particularly those compounds termed “small molecules” into the cells of mammalian tissue, such as the epithelial cells of the mucosa.
    Type: Application
    Filed: March 9, 2004
    Publication date: September 9, 2004
    Applicant: Aesgen, Inc.
    Inventors: Robert G. Petit, Esward C. Shinal
  • Patent number: 6268524
    Abstract: The invention provides amorphous disodium pamidronate having no more than about 1-2 wt-% water.
    Type: Grant
    Filed: August 15, 2000
    Date of Patent: July 31, 2001
    Assignee: Aesgen, Inc.
    Inventor: Edward C. Shinal
  • Patent number: 6211169
    Abstract: The invention provides a therapeutic calcitriol solution which is suitable for packaging into pharmaceutical vials without producing discoloration of the antioxidant component of the solution.
    Type: Grant
    Filed: September 29, 1999
    Date of Patent: April 3, 2001
    Assignee: Aesgen, Inc.
    Inventor: Edward C. Shinal
  • Patent number: 6160165
    Abstract: The invention includes a method for the preparation of disodium pamidronate comprising: (a) preparing a stirred slurry of pamidronate in water, (b) adding a solution of sodium hydroxide to give a clear solution at pH of about 6.5, (c) filtering the solution and (d) freezing and lyophilizing the solution to give an amorphous essentially anhydrous disodium pamidronate which contains .ltoreq.2 wt-% water.
    Type: Grant
    Filed: December 10, 1998
    Date of Patent: December 12, 2000
    Assignee: Aesgen, Inc.
    Inventor: Edward C. Shinal
  • Patent number: RE39485
    Abstract: Glutamine is administered orally at a rate of about 4.5 g/m2 per day to treat oropharyngeal mucositis. This is administered to patients that experience or may develop oropharyngeal mucositis, especially those caused by chemotherapy or radiotherapy.
    Type: Grant
    Filed: May 18, 2004
    Date of Patent: February 6, 2007
    Assignee: Aesgen, Inc.
    Inventors: Keith M. Skubitz, Peter M. Anderson